INCREASED TIME IN RANGE WITH SOTAGLIFLOZIN AS ADJUNCT THERAPY TO INSULIN IN ADULTS WITH TYPE 1 DIABETES DEMONSTRATED BY 24-WEEK CONTINUOUS GLUCOSE MONITORING (INTANDEM1, INTANDEM2)
DIABETES TECHNOLOGY & THERAPEUTICS（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要